Q&A with Dr Mitchell Smith - Charting Our Progress Towards a Cure Webinar

Listen to Dr Mitchell Smith answer key questions from our live audience at our webinar "Charting our Progress Towards a Cure in FL".

We had some unexpected technical issues towards the end of the webinar. As a result, this video addresses the main questions:

The difference between cure and functional cure​
Are we curing patients with bispecific antibodies?​
Can you share your experience with Bendamustine & Rituximab?
Can we predict who's going to do well after immunotherapy? ​
Do stress and the gut microbiome affect treatment success?​
Is AI being used in FL research?​

If you're unsure about any of the terms and treatments discussed, please visit our glossary: https://www.theflf.org/your-support-h...

You can register your interest in our webinars to be notified when you can register here: https://www.theflf.org/upcoming-webin...

If you've found our videos helpful, please consider donating to the Follicular Lymphoma Foundation. Your support helps us accelerate research towards a cure for FL and improve the lives of those affected: https://www.theflf.org/donate/

[Disclaimer: This video is intended for educational and disease awareness purposes only and the information presented and discussed does not constitute medical advice. The presentations contain data and information regarding not yet approved treatments and/or off-label use which are not to be construed as recommendations. Please consult with your healthcare provider for medical advice.]

Supported by an independent educational grant from AstraZeneca. Sponsorship support from BeOne Medicines USA, Inc. and Novartis, who provided funding. All funders have had no input into the content of the materials used in this webinar.